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Abstract
Background: Angioectasias in the gastrointestinal tract can be found in up to 3% of the population. They are
typically asymptomatic but may sometimes result in severe bleeding. The reasons for why some patients bleed
from their angioectasias are not fully understood but it has been reported that it may be explained by an acquired
von Willebrand syndrome (AVWS). This condition has similar laboratory findings to congenital von Willebrand
disease with selective loss of large von Willebrand multimers. The aim of this study was to find out if AVWS or any
other bleeding disorder was more common in patients with bleeding from angioectasias than in a control group.
Methods: We compared bleeding tests and coagulation parameters, including von Willebrand multimers, from a
group of 23 patients with anemia caused by bleeding from angioectasias, with the results from a control group
lacking angioectasias.
Results: No significant differences between the two groups were found in coagulation parameters, bleeding time
or von Willebrand multimer levels.
Conclusion: These results do not support a need for routine bleeding tests in cases of bleeding from
angioectasias and do not show an overall increased risk of AVWS among these patients.
Background
Angioectasias, also named angiodysplasias in the litera-
ture, are vascular malformations that can be found
throughout the gastrointestinal tract, with the most
common site being the right colon [1,2]. These lesions
may occasionally cause severe bleeding but they can also
be found in symptom-free patients. In terms of patient
presentation, angioectasias are most common in eldery
patients undergoing an evaluation for gastrointestinal
bleeding. Angioectasias are proposed to be the result of
a degenerative process. The prevalence is estimated to
0.9-3.0% in non-bleeding patients and up to 6% in
patients with evidence of blood loss [3].
The reason why some patients bleed from their angioec-
tasias and some do not is not yet understood. Chronic
renal failure is one mechanism that has been reported in
association with bleeding from angioectasias [4].
In 1957 Heyde was the first to report about several
patients with aortic stenosis who had massive gastroin-
testinal bleeding of unknown origin [5]. This publication
was followed by larger studies that confirmed this asso-
ciation [6,7]. Selective angiography and subsequent
endoscopic techniques allowing direct visualization of
the mucosa revealed the appearance of angioectasias as
a probable source of bleeding [8]. Thus the connection
between aortic stenosis and bleeding from gastrointest-
inal angioectasias became known as Heyde’s syndrome.
During the 1980’s Heyde’s syndrome was questioned in
several case-control studies where the association
between aortic stenosis and angioectasias could not be
reproduced [9,10] but then finally confirmed by Pate et
al in a large retrospective study [11]. The link between
aortic stenosis and bleeding from angioectasias has been
suggested to be an acquired form of von Willebrand
disease.
The von Willebrand factor (VWF) molecules are of
different sizes, varying from 500 to >20,000 kD. These
molecules adhere to platelets when bleeding occurs,
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(AVWS) is a rare bleeding disorder with many similari-
ties to congenital von Willebrand disease (VWD). There
are many causes for AVWS including lympho- or mye-
loproliferative disorders, solid tumours, auto-antibodies
against VWF and cardiovascular disorders [12-14]. Vas-
cular abnormalities, such as aortic stenosis, may cause
increased shear rate of the flowing blood that lead to
degradation of large VWF multimers in plasma through
proteolytic cleavages. The result is an acquired loss of
the largest multimers of the von Willebrand complexes
[15-17]. These large multimers are important in main-
taining hemostasis under the conditions of increased
wall shear rates that are also found in angioectasias.
This may explain why angioectasias could bleed without
an underlying bleeding tendency [8].
When a stenotic aortic valve is surgically removed and
replaced with a mechanical valve, previous bleeding
from angioectasias stops and coagulation parameters
normalize [8,18,19].
Therefore, AVWS may be expected to be found in
patients with bleeding angioectasias. Precisely this corre-
lation was observed in a small study by Veyradier et al
[20]. In this study eight of nine consecutive patients
with bleeding from angioectasias had a loss of the lar-
gest multimers of the VWF. When examined with echo-
cardiography seven of eight patients with AVWS also
had aortic valve disease.
I ft h ep r e v a l e n c eo fA V W Si sa sh i g ha st h es t u d yb y
Veyradier et al suggests, should clinicians perform
laboratory tests of VWF in all patients with bleeding
from angioectasias? Should these patients be evaluated
for aortic valve disease? Should these patients be routi-
nely tested for other bleeding deficiencies?
The aim of this study was to test if unselected patients
diagnosed with anemia caused by bleeding from gastro-
intestinal angioectasias had AVWS or any other bleed-
ing disorder, as determined by abnormal bleeding
parameters or loss of coagulation factors. The results of
the study group were compared to those from a control
group of patients without gastrointestinal angioectasias.
Echocardiography was not considered necessary in the
case of normal levels of VWF multimers.
Methods
Twenty-five patients with a previous history of gastroin-
testinal bleeding due to angioectasias in the gastrointest-
inal tract were identified between 2003 and 2006 using
the records of the Department of Gastroenterology at
the Stockholm Söder Hospital. These patients were ret-
rospectively enrolled in the study. Two participants were
subsequently excluded from the study because of find-
ings suggestive of an on-going malignancy that could
have interfered with the bleeding test results. The mean
age of the remaining 23 patients was 72 years (35-86).
Fifteen of the patients were female (65%). All study par-
ticipants had gastrointestinal bleeding that was sufficient
to cause anemia and 15 participants had been treated
with blood transfusions (two units or more). All study
participants had undergone upper and lower endoscopy
(GIF-160, TL/PCF-160, Olympus Sweden AB, Solna,
Sweden) performed by gastroenterologists at our endo-
scopy unit. Angioectasias were found in the upper gas-
trointestinal tract in seven patients, in the lower tract in
seven patients, in the small intestine in five patients and
in multiple locations in four patients. Angioectasias
found in the small intestine were diagnosed by means of
capsule enteroscopy (PillCam, Given, Yoqneam, Israel).
Capsule enteroscopy was performed in patients where
no plausible bleeding source was found by means of gas-
tro- and colonoscopy or if bleeding reoccurred after
endoscopic treatment of the angioectasias. The diagnosis
of angioectasia was based upon endoscope findings of a
flat bright reddish lesion, measuring 3-10 mm with a
typical appearance (fig 1). The angioectasias were con-
sidered to be the only source of bleeding in the study
group.
These patients were compared to a retrospective con-
trol group consisting of 24 patients diagnosed with
diverticulosis, also identified from the records of the
Department of Gastroenterology at the Stockholm Söder
Hospital spanning the same time period as the study
group. The mean age of the control group was 73 (35-86)
years and 15 were females (62%). All patients in the
control group had a gastroscopy and a colonoscopy
Figure 1 Angioectasia in the jejunum detected by capsule
enteroscopy. Patient from the study group.
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tions for endoscopy were gastrointestinal bleeding,
abdominal pain or diarrhoea. The control group was of
same gender and age composition as the study group
which is why matched controls were not considered
necessary.
Exclusion criteria for both groups were malignancy,
the use of warfarin during the bleeding episode, the
absolute need for drugs affecting bleeding parameters,
known bleeding disorder, thrombocytopenia, kidney fail-
ure (i.e. serum creatinin concentration above 150 mmol/L),
alcoholic over-consumption and severe psychiatric illness.
The participants were contacted by phone and were
subsequently given written information. Patients
enrolled were asked to leave blood samples on one
occasion.
All drugs that might affect bleeding parameters were
stopped two weeks before blood tests were performed.
The participants were tested for haemoglobin level,
platelet count, serum creatinin and activated partial
thromboplastin (APT) time. Bleeding time (according to
Ivy) was tested utilising a Surgicutt™ device from Inter-
national Technidyne Corporation (Edison, NJ, USA). For
coagulation analysis, blood was collected in Vacutainer
tubes containing 1/10 volume sodium citrate, then
plasma was separated immediately after blood collection.
Plasma was stored at -70°C until analysis. Factor VIII
was measured with a chromogenic assay (Chromogenix,
Milan, Italy), prothrombin time (PT-INR) with the
reagent GHI-131 (Medirox, Nyköping, Sweden), von
Willebrand-antigen (VW-ag) and von Willebrand-activ-
ity (VW-act) with reagents from Instrumentation
Laboratory (Milan, Italy) utilising an ACL Top (IL). All
tests were performed at the coagulation laboratory of
Linköping University Hospital and were calibrated with
manufacturer assigned values through comparison with
the WHO reference materials. The laboratory is accredi-
tated according to the standard EN 45001 by the Swedish
board for Accreditation and Conformity Assessment
(SWEDAC). The results from the external control
scheme ECAT were good. The imprecision for vW-act
was for the control with mean 1.13 kIE/L C.V. 5.6% (n
= 54) and for control with mean 0.29 kIE/L C.V. 7.7%
(n = 52), respectively.
Von Willebrand-multimer (vW-multimer) was analysed
with SDS-gelelectrophoresis and von Willebrand-multimer
(VW-multimer) with SDS-gelelectrophoresis followed by
western blot (fig 2). The multimeric pattern of VWF in
plasma was analyzed by electrophoresis in 1,9% SeaKem®
HGT(P) agarose gel (Lonza, Rockland, ME, USA) in the
presence of sodium dodecyl sulphate followed by immu-
noblotting with antibodies against VWF as previously
described [21,22]. The multimeric distribution was there-
after quantitated using densitometric analysis where peaks
1 through 5 represents small, peaks 6 through 10 inter-
mediate and peaks above 10 large multimers as described
by Budde et al [23]. Blood sampling and bleeding-time
were performed by one single nurse at our unit during
2006.
Median values with range were used in the text. Non
parametric statistics of mean values were used for
comparison.
The study was approved by the Ethics Committee in
Stockholm (Etikprövningsnämnden, Stockholm, Sweden).
Results
Hemoglobin was significantly lower in the study group
compared to the control group (129 vs 139, p = 0,0294).
There was no significant difference in any of the other
Figure 2 Western blot shows a slightly depleted level of large
von Willebrand multimers in one of the study patients (right)
and a patient with normal levels (left).
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in Table 1.
Although the results of the whole study group did not
significantly differ from those of the control group, two
patients in the study group were found to have slightly
depleted levels of the largest multimers of von Willebrand
(both 20%, normal level 22-27%), table 2.
Patient 1 was an 82 year old woman with a history of
chronic obstructive lung disease and a severe aortic ste-
nosis. She had experienced repeated anemia due to mul-
tiple angioectasias in both the duodenum and the
caecum. The angioectasias had been treated by means of
argon plasma coagulation for several times but the
bleeding had reoccurred. All bleeding parameters except
the level of large VW-multimer were normal. Currently
she needs blood transfusions twice a year.
Patient 2 was a 70 year old woman. She had an acute
myocardial infarction in 2002 and was treated with pri-
mary coronary intervention. Echocardiography showed
an aortic stenosis of medium significance. Anemia was
also found. This was due to several angioectasias in the
duodenum that was treated repeatedly with argon
plasma coagulation. The anemia persisted in spite of
treatment and therefore capsule enteroscopy was per-
formed which revealed multiple angioectasias in the
jejunum. The angioectasias were treated by means of
argon plasma coagulation during peroperative entero-
scopy. A subsequent attempt at a second treatment by
means of double balloon enteroscopy failed due to stric-
tures in the small intestine. In the last year the patient’s
haemoglobin level has remained stable without further.
Another two patients in the study group had a pro-
longed bleeding time (>900s) but no other abnormalities
were found in their blood chemistry parameters (table 2,
“patient 3 and 4”). Their history did not reveal a general
bleeding tendency apart from the fact that they had had
bleeding from an angioectesia that stopped after endo-
scopic treatment by means of argon plasma coagulation.
The first patient declined further follow-up but the sec-
ond patient went through a more thorough investigation
of coagulation where the only abnormal finding was a
second prolonged bleeding time of 540 s. Neither of
them had noticed a general bleeding tendency.
Discussion
Gastrointestinal angioectasias are most commonly found
i ne l d e r l yp e o p l ea n dm a yi ns o m ei n d i v i d u a l sc a u s e
bleeding that can be massive. The reasons for why
angioectasias tend to bleed in some cases and not in
others are not fully understood. A connection between
bleeding from angioectasias and aortic stenosis known
Table 1 A comparison of coagulation parameters between 23 patients with bleeding from angioectasias and 24
controls
Parameter Study group, mean (min-max) Control group, mean (min-max) Significance, P-value < 0,05
Hemoglobin level, g/L 128 (97-151) 141 (113-169) 0,0294
Platelet count, 10
9/L 262 (140-457) 265 (176-562) NS
Creatinin, mmol/L 75 (56-136) 76 (62-112) NS
C-reactive protein, mmol/L <10 (<10-25) <10 (<10-20) NS
PT-INR 1,0 (0,9-1,2) 1,1 (0,9-1,2) NS
APT-time, sec 35 (28-47) 34 (27-41) NS
VW-antigen, kIU/L 1,47 (0,68-3,63) 1,50 (0,68-2,48) NS
VW-activity, kIU/L 1,20 (0,70-3,39) 1,20 (0,69-2,23) NS
Factor VIII, kIU/L 2,00 (1,01-3,84) 2,0 (0,99-2,52) NS
Fibrinogen, g/L 3,9 (2,8-5,5) 3,9 (2,9-4,7) NS
Large VW-multimer, % 28,4 (20,4-32,4) 29,9 (24,1-37,5) NS
Bleeding time (Ivy), sec Median* = 270 (130->900) Median* = 250 (149-570) NS
* = Median was used instead of mean because the value could not be measured above a certain level.
Table 2 Laboratory values of patients with abnormal
high molecular weight VWF or bleeding time (Ivy)
Parameter Patient
1
Patient
2
Patient
3
Patient
4
Hemoglobin level, g/L 128 125 126 134
Platelet count, 10
9/L 337 323 150 220
Creatinin, mmol/L 79 70 90 64
C-reactive protein, mmol/L <10 <10 <10 <10
PT-INR 1,0 0,9 1,1 1,0
APT-time, sec 43 38 33 37
VW-antigen, kIU/L 1,12 2,20 2,23 1,20
VW-activity, kIU/L 0,74 1,43 2,04 1,03
Factor VIII, kIU/L 1,15 2,04 2,12 1,79
Fibrinogen, g/L 5,4 5,5 2,8 3,7
Large VW-multimer, % 20,4 20,6 28 31,4
Bleeding time (Ivy), sec 220 165 >900 >900
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many years. The link between those two diagnoses was
found to be acquired von Willebrand syndrome. The
aim of this study was to find out if AVWS or any other
bleeding disorder was found in higher frequency in
patients with a history of bleeding from angioectasias
than in a control group. A small study has previously
implied a high frequency of AVWS due to cardiovascu-
lar disease in a similar study group [20]. It is of clinical
importance to know if all patients with bleeding from
angioectasias should be routinely tested for bleeding
disorders.
In this study, after comparison of bleeding tests and
coagulation parameters between study and control
groups, no relationship between bleeding from gastroin-
testinal angioectasias and acquired AVWS or any other
bleeding disorder was identified. Only hemoglobin levels
differed significantly. If an even larger study group is
needed for showing a possible relationship between
bleeding from angioectasias and a bleeding disorder,
those results would still at the best indicate a very weak
relation.
Interestingly there were two patients in the study
group who had slightly decreased levels of the largest
multimers of von Willebrand. These patients also had
known aortic stenosis which is a risk factor for AVWS
[8,17,18]. Two other patients had a prolonged bleeding
time of more than 900 s. This test though has a low
specificity [24] and its diagnostic value is uncertain [25].
At follow up no signs of any general bleeding tendency
or bleeding from the intestine after initial treatment of
angioectasias were found.
The fact that the blood sampling in most cases was
not performed when the bleeding occurred is a limita-
tion of our study. However, since we were seeking a
chronic bleeding tendency the time point for blood
sampling was not considered a major issue. Another
limitation of the study is that a majority of the patients
identified with bleeding from angiectasias met one of
the exclusion criteria or were unwilling to participate,
thus excluding them from enrollement. The median
age of the study population was rather high (72 years)
reflecting that angioectasias are of degenerative nature
[3] and bleeding from those are reported to be com-
mon among elder patients with aortic stenosis [26].
High age is also a risk factor for comorbidity leading
to exclusion from the study. Screening for aortic valve
disease with echocardiography was not included in the
study design, because our intention was not to confirm
an association between AVWS and aortic stenosis. The
two patients from the study group with depleted levels
of large VW-multimers had known aortic stenosis
already confirmed by echocardiography before the
onset of the study.
The question of why some patients tend to bleed from
their angioectasias is neither fully answered by findings
of AVWS nor by any other coagulation disorder tested
for in this study. Chronic renal failure was one of the
exclusion criterions but might otherwise be a factor of
some importance. High age is another factor that can be
supposed to increase the risk. These results may reflect
that bleeding from angioectasias is caused by multiple
factors where some of them may still be unknown.
Conclusions
Based on the observations in this study we suggest that
there is no need for routine testing for acquired von
Willebrand disease or other bleeding disorders in
patients with bleeding from gastrointestinal angioecta-
sias. In cases of known aortic stenosis or repeated bleed-
ing from the angioectasias, testing of VWF multimers
might be considered.
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